Single answer
Is Avenue Therapeutics Inc (ATXI) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Avenue Therapeutics Inc is $12.00, which is $11.32 (1,664.19%) above the current price today's price.
Low target: $12.00 | High target: $12.00
Company snapshot
A quick overview of the business and its public profile.
Avenue Therapeutics Inc a specialty pharmaceutical company develops and commercializes products primarily for use in the acuteintensive care hospital setting Its product candidate is intravenous Tramadol a synthetic dualacting opioid which is in Phase III clinical trials for the treatment of postoperative acute pain The company was incorporated in 2015 and is based in New York New York
Website: https://www.avenuetx.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: 0.00. Net profit margin: 53.42%. Inflation risk score: low (0.30/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for Avenue Therapeutics Inc is $3,495. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
We cannot find data for Avenue Therapeutics Inc 10 years ago, but if you had invested on 2017-06-27 when the price was $9,281.27, you would have made a loss of $9,280.58 per share or 99.99%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.